Literature DB >> 30048623

Toxicological status of nanoparticles: What we know and what we don't know.

Wided N Missaoui1, Robert D Arnold2, Brian S Cummings3.   

Abstract

The field of nanotechnology has grown exponentially during the last few decades, due in part to the use of nanoparticles in many manufacturing processes, as well as their potential as clinical agents for treatment of diseases and for drug delivery. This has created several new avenues by which humans can be exposed to nanoparticles. Unfortunately, investigations assessing the toxicological impacts of nanoparticles (i.e. nanotoxicity), as well as their possible risks to human health and the environment, have not kept pace with the rapid rise in their use. This has created a gap-in-knowledge and a substantial need for more research. Studies are needed to help complete our understanding of the mechanisms of toxicity of nanoparticles, as well as the mechanisms mediating their distribution and accumulation in cells and tissues and their elimination from the body. This review summarizes our knowledge on nanoparticles, including their various applications, routes of exposure, their potential toxicity and risks to human health.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell death; Drug delivery; Nanoparticles; Nanotoxicology; Toxicology

Mesh:

Year:  2018        PMID: 30048623     DOI: 10.1016/j.cbi.2018.07.015

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  14 in total

1.  Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.

Authors:  Puja Sandbhor; Jayant Goda; Bhabani Mohanty; Poonam Gera; Sandhya Yadav; Godanjali Chekuri; Pradip Chaudhari; Shilpee Dutt; Rinti Banerjee
Journal:  Drug Deliv Transl Res       Date:  2022-10-16       Impact factor: 5.671

2.  Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation.

Authors:  Priya Singh; Deepika Singh; Pratikshya Sa; Priyanka Mohapatra; Auromira Khuntia; Sanjeeb K Sahoo
Journal:  Nanomedicine (Lond)       Date:  2021-05-17       Impact factor: 5.307

3.  Toxicogenomic Profiling of 28 Nanomaterials in Mouse Airways.

Authors:  Pia A S Kinaret; Joseph Ndika; Marit Ilves; Henrik Wolff; Gerard Vales; Hannu Norppa; Kai Savolainen; Tiina Skoog; Juha Kere; Sergio Moya; Richard D Handy; Piia Karisola; Bengt Fadeel; Dario Greco; Harri Alenius
Journal:  Adv Sci (Weinh)       Date:  2021-03-08       Impact factor: 16.806

Review 4.  Resveratrol-loaded nanomedicines for cancer applications.

Authors:  Manjusha Annaji; Ishwor Poudel; Sai H S Boddu; Robert D Arnold; Amit K Tiwari; R Jayachandra Babu
Journal:  Cancer Rep (Hoboken)       Date:  2021-03-02

Review 5.  Epigenetic Effects of Nanomaterials and Nanoparticles.

Authors:  Marta Pogribna; George Hammons
Journal:  J Nanobiotechnology       Date:  2021-01-06       Impact factor: 10.435

Review 6.  Safe Nanoparticles: Are We There Yet?

Authors:  Wided Najahi-Missaoui; Robert D Arnold; Brian S Cummings
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

Review 7.  Complex Factors and Challenges that Affect the Pharmacology, Safety and Efficacy of Nanocarrier Drug Delivery Systems.

Authors:  Joseph A Piscatelli; Jisun Ban; Andrew T Lucas; William C Zamboni
Journal:  Pharmaceutics       Date:  2021-01-17       Impact factor: 6.321

8.  Bioremoval of PVP-coated silver nanoparticles using Aspergillus niger: the role of exopolysaccharides.

Authors:  Ola M Gomaa; Amar Yasser Jassim; Anindya Chanda
Journal:  Environ Sci Pollut Res Int       Date:  2022-01-10       Impact factor: 5.190

9.  Quartz crystal microbalances (QCM) are suitable for real-time dosimetry in nanotoxicological studies using VITROCELL®Cloud cell exposure systems.

Authors:  Yaobo Ding; Patrick Weindl; Anke-Gabriele Lenz; Paula Mayer; Tobias Krebs; Otmar Schmid
Journal:  Part Fibre Toxicol       Date:  2020-09-16       Impact factor: 9.400

10.  Combination of the BeWo b30 placental transport model and the embryonic stem cell test to assess the potential developmental toxicity of silver nanoparticles.

Authors:  Ashraf Abdelkhaliq; Meike van der Zande; Ruud J B Peters; Hans Bouwmeester
Journal:  Part Fibre Toxicol       Date:  2020-03-10       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.